Johnson & Johnson (JNJ) will release its first-quarter 2022 financial results on April 29. The corporation has been in the healthcare industry for a long time and provides products across the Consumer, Pharmaceutical, and Medical Devices segments. The company recorded strong profit results in the most recent fourth quarter, with both the top and bottom lines increasing year-over-year. Sales increased by 10.4% year-over-year to $24.8 billion, while adjusted EPS improved by 14.5% to $2.13. With a market capitalization of $473.7 billion, JNJ stock has grown 14% in value over the last year. Let's examine how the company is expected to perform this quarter.
https://www.tipranks.com/news/article/all-eyes-on-johnson-johnson-as-it-reports-q1-earnings?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Johnson and Johnson Charts.